Influence of donor IVIG intervention on recipient infection after organ transplantation: a randomized controlled trial.

Influence of donor IVIG intervention on recipient infection after organ transplantation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036107

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Transplantation

Interventions

experimental group:IVIG

control group:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) The donor was between 14 and 60 years old, and the recipient was between 18 and 70 years old; (2) Donors and their corresponding recipients have two days of IVIG use time before organ transplantation; (3) The recipient has not underwent organ transplantation yet.

Exclusion criteria

Exclusion criteria: (1) The recipient was a patient in another hospital, and the detailed etiological results could not be tracked. (2) The family member of the donor refuses to sign the informed consent; (3) The recipient was infected before the transplant.

Design outcomes

Primary

Measure	Time frame
Metagenomic detection;	—

Secondary

Measure	Time frame
PCT;(1,3)-ß-D-glucan test;GM test;CRP;	—

Countries

China

Contacts

Public ContactJinghui Yang

Shanghai Changzheng Hospital

yjh@smmu.edu.cn+86 18521311650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026